Pharmacoepidemiology

860 publications in "Pharmacoepidemiology"

Aug-07

Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease

Musculoskeletal Pharmacoepidemiology Respiratory

Read more

Jun-07

Effectiveness of switch from NPH to Glargine in type 2 Diabetics

Endocrinology Pharmacoepidemiology

Read more

Jun-07

Real Life Effectiveness Of Initiation Of Basal Insulin In Type 2 Insulin Na[iuml]ve Diabetic Patients: Glargine Vs. Nph Vs. Detemir

Endocrinology Pharmacoepidemiology

Read more

Jun-07

Real Life Data On The Switch From Nph To Glargine In Type 1 Diabetics

Endocrinology Pharmacoepidemiology

Read more

May-07

The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Patients with Type 2 Diabetes Mellitus

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

May-07

The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Type 1 Diabetes Mellitus

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

May-07

The True versus the Perceived Lipid Profile of the UK Population in Need of Statin Therapy

Pharmacoepidemiology

Read more

Apr-07

Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK

Men's Health Pharmacoepidemiology

Read more

Apr-07

Non-steroidal anti-inflammatory drugs and risk of lung cancer

Oncology Pharmacoepidemiology Respiratory

Read more

Feb-07

The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

Feb-07

Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population

Gastroenterology Pharmacoepidemiology

Read more

Feb-07

The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

Endocrinology Pharmacoepidemiology

Read more
Date Title Categories
Aug-07 Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease

Musculoskeletal Pharmacoepidemiology Respiratory

Jun-07 Effectiveness of switch from NPH to Glargine in type 2 Diabetics

Endocrinology Pharmacoepidemiology

Jun-07 Real Life Effectiveness Of Initiation Of Basal Insulin In Type 2 Insulin Na[iuml]ve Diabetic Patients: Glargine Vs. Nph Vs. Detemir

Endocrinology Pharmacoepidemiology

Jun-07 Real Life Data On The Switch From Nph To Glargine In Type 1 Diabetics

Endocrinology Pharmacoepidemiology

May-07 The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Patients with Type 2 Diabetes Mellitus

Endocrinology Healthcare Cost Pharmacoepidemiology

May-07 The Relative Cost Effectiveness of Insulin Glargine Versus NPH Insulin Using UK Real Life Data in Type 1 Diabetes Mellitus

Endocrinology Healthcare Cost Pharmacoepidemiology

May-07 The True versus the Perceived Lipid Profile of the UK Population in Need of Statin Therapy

Pharmacoepidemiology

Apr-07 Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK

Men's Health Pharmacoepidemiology

Apr-07 Non-steroidal anti-inflammatory drugs and risk of lung cancer

Oncology Pharmacoepidemiology Respiratory

Feb-07 The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

Endocrinology Healthcare Cost Pharmacoepidemiology

Feb-07 Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population

Gastroenterology Pharmacoepidemiology

Feb-07 The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

Endocrinology Pharmacoepidemiology

1 68 69 70 71 72